These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 16418399)

  • 21. IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice.
    Lopez Kostka S; Dinges S; Griewank K; Iwakura Y; Udey MC; von Stebut E
    J Immunol; 2009 Mar; 182(5):3039-46. PubMed ID: 19234200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells.
    Bertholet S; Debrabant A; Afrin F; Caler E; Mendez S; Tabbara KS; Belkaid Y; Sacks DL
    Infect Immun; 2005 Oct; 73(10):6620-8. PubMed ID: 16177338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory Dendritic Cells, Regulated by IL-4 Receptor Alpha Signaling, Control Replication, and Dissemination of
    Hurdayal R; Nieuwenhuizen NE; Khutlang R; Brombacher F
    Front Cell Infect Microbiol; 2019; 9():479. PubMed ID: 32039054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T cell hypo-responsiveness against Leishmania major in MAP kinase phosphatase (MKP) 2 deficient C57BL/6 mice does not alter the healer disease phenotype.
    Schroeder J; McGachy HA; Woods S; Plevin R; Alexander J
    PLoS Negl Trop Dis; 2013; 7(2):e2064. PubMed ID: 23437409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Requirements for Th1-dependent immunity against infection with Leishmania major.
    von Stebut E; Udey MC
    Microbes Infect; 2004 Oct; 6(12):1102-9. PubMed ID: 15380780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.
    Padigel UM; Farrell JP
    J Immunol; 2005 May; 174(10):6340-5. PubMed ID: 15879134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA155 Plays a Critical Role in the Pathogenesis of Cutaneous Leishmania major Infection by Promoting a Th2 Response and Attenuating Dendritic Cell Activity.
    Varikuti S; Verma C; Natarajan G; Oghumu S; Satoskar AR
    Am J Pathol; 2021 May; 191(5):809-816. PubMed ID: 33539779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STAT1 expression in dendritic cells, but not T cells, is required for immunity to Leishmania major.
    Johnson LM; Scott P
    J Immunol; 2007 Jun; 178(11):7259-66. PubMed ID: 17513775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of IL-10 in promoting disease progression in leishmaniasis.
    Kane MM; Mosser DM
    J Immunol; 2001 Jan; 166(2):1141-7. PubMed ID: 11145695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major.
    Noben-Trauth N; Lira R; Nagase H; Paul WE; Sacks DL
    J Immunol; 2003 May; 170(10):5152-8. PubMed ID: 12734362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural killer cells support the induction of protective immunity during dendritic cell-mediated vaccination against Leishmania major.
    Remer KA; Roeger B; Hambrecht C; Moll H
    Immunology; 2010 Dec; 131(4):570-82. PubMed ID: 20673238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TLR9-dependent activation of dendritic cells by DNA from Leishmania major favors Th1 cell development and the resolution of lesions.
    Abou Fakher FH; Rachinel N; Klimczak M; Louis J; Doyen N
    J Immunol; 2009 Feb; 182(3):1386-96. PubMed ID: 19155485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendritic cell-derived IL-12p40 homodimer contributes to susceptibility in cutaneous leishmaniasis in BALB/c mice.
    Nigg AP; Zahn S; Rückerl D; Hölscher C; Yoshimoto T; Ehrchen JM; Wölbing F; Udey MC; von Stebut E
    J Immunol; 2007 Jun; 178(11):7251-8. PubMed ID: 17513774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Miltefosine efficiently eliminates Leishmania major amastigotes from infected murine dendritic cells without altering their immune functions.
    Griewank K; Gazeau C; Eichhorn A; von Stebut E
    Antimicrob Agents Chemother; 2010 Feb; 54(2):652-9. PubMed ID: 19995922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
    Halliday A; Bates PA; Chance ML; Taylor MJ
    Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LIGHT Is critical for IL-12 production by dendritic cells, optimal CD4+ Th1 cell response, and resistance to Leishmania major.
    Xu G; Liu D; Okwor I; Wang Y; Korner H; Kung SK; Fu YX; Uzonna JE
    J Immunol; 2007 Nov; 179(10):6901-9. PubMed ID: 17982081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice.
    De Trez C; Magez S; Akira S; Ryffel B; Carlier Y; Muraille E
    PLoS Pathog; 2009 Jun; 5(6):e1000494. PubMed ID: 19557162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NF-kappa B1 is required for optimal CD4+ Th1 cell development and resistance to Leishmania major.
    Artis D; Speirs K; Joyce K; Goldschmidt M; Caamaño J; Hunter CA; Scott P
    J Immunol; 2003 Feb; 170(4):1995-2003. PubMed ID: 12574369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis.
    Ritter U; Meissner A; Scheidig C; Körner H
    Eur J Immunol; 2004 Jun; 34(6):1542-50. PubMed ID: 15162423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amastigote load and cell surface phenotype of infected cells from lesions and lymph nodes of susceptible and resistant mice infected with Leishmania major.
    Muraille E; De Trez C; Pajak B; Torrentera FA; De Baetselier P; Leo O; Carlier Y
    Infect Immun; 2003 May; 71(5):2704-15. PubMed ID: 12704145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.